FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1999585013> ?p ?o ?g. }

• W1999585013 endingPage "253" @default.
• W1999585013 startingPage "247" @default.
• W1999585013 abstract "Using the breast carcinoma cell line MDA-MB 468 as immunogen, we have produced six new rat monoclonal antibodies (mAbs) against the human EGF receptor (EGFR) and are investigating their use for diagnostic and therapeutic applications in cancer patients whose tumours overexpress these receptors. The mAbs (three IgG2b and one each of IgG2a, IgG1 and IgA) were selected on the basis that they bound to the extracellular domain of the EGFR and blocked growth factor-receptor interaction. Competitive assays showed that, with the exception of antibody ICR65, the mAbs bound to one of two distinct epitopes on the external domain of the EGFR. ICR65, however, cross-reacted with mAbs binding to both epitopes. All of the mAbs immunoprecipitated the 170 kDa glycoprotein from cells expressing the EGFR but not the 185 kDa product of the related c-erbB-2 proto-oncogene. Unlike EGF and TGF alpha none of the mAbs stimulated the growth of quiescent human foreskin fibroblasts but they inhibited the EGF and TGF alpha induced growth stimulation of these cells in vitro. When tested for their effect on tumour cells the mAbs were found to inhibit the growth in vitro of a number of human tumours that overexpressed the EGFR (e.g. HN5, HN6, HN15, A431, MDA-MB 468) but they were without effect on tumour cell lines expressing low or undetectable amounts of the receptor. Our initial results indicate that this new generation of antibodies which bind with high affinity to the EGFR, block growth factor-receptor interaction and inhibit the growth of human squamous carcinoma cell lines overexpressing the receptor have potential for clinical application." @default.
• W1999585013 created "2016-06-24" @default.
• W1999585013 creator A5001513716 @default.
• W1999585013 creator A5010891764 @default.
• W1999585013 creator A5046133606 @default.
• W1999585013 date "1993-02-01" @default.
• W1999585013 modified "2023-10-14" @default.
• W1999585013 title "The human EGF receptor as a target for cancer therapy: six new rat mAbs against the receptor on the breast carcinoma MDA-MB 468" @default.
• W1999585013 cites W135877420 @default.
• W1999585013 cites W1472721622 @default.
• W1999585013 cites W1492028808 @default.
• W1999585013 cites W1514220960 @default.
• W1999585013 cites W1529786888 @default.
• W1999585013 cites W1605302012 @default.
• W1999585013 cites W1627068912 @default.
• W1999585013 cites W1974027176 @default.
• W1999585013 cites W1979040485 @default.
• W1999585013 cites W2009919126 @default.
• W1999585013 cites W2010201035 @default.
• W1999585013 cites W2019691808 @default.
• W1999585013 cites W2031368014 @default.
• W1999585013 cites W2032359283 @default.
• W1999585013 cites W2034185792 @default.
• W1999585013 cites W2035432922 @default.
• W1999585013 cites W2041808732 @default.
• W1999585013 cites W2047525856 @default.
• W1999585013 cites W2058426435 @default.
• W1999585013 cites W2061210157 @default.
• W1999585013 cites W2062468721 @default.
• W1999585013 cites W2080580789 @default.
• W1999585013 cites W2096199069 @default.
• W1999585013 cites W2099182146 @default.
• W1999585013 cites W2099357201 @default.
• W1999585013 cites W2103932821 @default.
• W1999585013 cites W2149051154 @default.
• W1999585013 cites W2150268629 @default.
• W1999585013 cites W2154523090 @default.
• W1999585013 cites W2339422318 @default.
• W1999585013 cites W279929881 @default.
• W1999585013 cites W312361018 @default.
• W1999585013 cites W3140604265 @default.
• W1999585013 cites W74992319 @default.
• W1999585013 cites W7990268 @default.
• W1999585013 doi "https://doi.org/10.1038/bjc.1993.48" @default.
• W1999585013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1968163" @default.
• W1999585013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8094290" @default.
• W1999585013 hasPublicationYear "1993" @default.
• W1999585013 type Work @default.
• W1999585013 sameAs 1999585013 @default.
• W1999585013 citedByCount "53" @default.
• W1999585013 countsByYear W19995850132012 @default.
• W1999585013 countsByYear W19995850132013 @default.
• W1999585013 countsByYear W19995850132014 @default.
• W1999585013 countsByYear W19995850132015 @default.
• W1999585013 countsByYear W19995850132017 @default.
• W1999585013 countsByYear W19995850132018 @default.
• W1999585013 countsByYear W19995850132019 @default.
• W1999585013 countsByYear W19995850132020 @default.
• W1999585013 crossrefType "journal-article" @default.
• W1999585013 hasAuthorship W1999585013A5001513716 @default.
• W1999585013 hasAuthorship W1999585013A5010891764 @default.
• W1999585013 hasAuthorship W1999585013A5046133606 @default.
• W1999585013 hasBestOaLocation W19995850132 @default.
• W1999585013 hasConcept C153911025 @default.
• W1999585013 hasConcept C159654299 @default.
• W1999585013 hasConcept C170493617 @default.
• W1999585013 hasConcept C195616568 @default.
• W1999585013 hasConcept C203014093 @default.
• W1999585013 hasConcept C26375932 @default.
• W1999585013 hasConcept C2776362946 @default.
• W1999585013 hasConcept C2779438470 @default.
• W1999585013 hasConcept C2779909307 @default.
• W1999585013 hasConcept C502942594 @default.
• W1999585013 hasConcept C542903549 @default.
• W1999585013 hasConcept C54355233 @default.
• W1999585013 hasConcept C55493867 @default.
• W1999585013 hasConcept C81885089 @default.
• W1999585013 hasConcept C86803240 @default.
• W1999585013 hasConceptScore W1999585013C153911025 @default.
• W1999585013 hasConceptScore W1999585013C159654299 @default.
• W1999585013 hasConceptScore W1999585013C170493617 @default.
• W1999585013 hasConceptScore W1999585013C195616568 @default.
• W1999585013 hasConceptScore W1999585013C203014093 @default.
• W1999585013 hasConceptScore W1999585013C26375932 @default.
• W1999585013 hasConceptScore W1999585013C2776362946 @default.
• W1999585013 hasConceptScore W1999585013C2779438470 @default.
• W1999585013 hasConceptScore W1999585013C2779909307 @default.
• W1999585013 hasConceptScore W1999585013C502942594 @default.
• W1999585013 hasConceptScore W1999585013C542903549 @default.
• W1999585013 hasConceptScore W1999585013C54355233 @default.
• W1999585013 hasConceptScore W1999585013C55493867 @default.
• W1999585013 hasConceptScore W1999585013C81885089 @default.
• W1999585013 hasConceptScore W1999585013C86803240 @default.
• W1999585013 hasIssue "2" @default.
• W1999585013 hasLocation W19995850131 @default.
• W1999585013 hasLocation W19995850132 @default.
• W1999585013 hasLocation W19995850133 @default.
• W1999585013 hasLocation W19995850134 @default.

• next